Dwight Reynolds to Treatment Outcome
This is a "connection" page, showing publications Dwight Reynolds has written about Treatment Outcome.
Connection Strength
0.738
-
Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study. Pacing Clin Electrophysiol. 2017 Jul; 40(7):834-842.
Score: 0.091
-
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
Score: 0.090
-
Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
Score: 0.070
-
Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7.
Score: 0.065
-
A new paradigm of cardiovascular risk factor modification. Vasc Health Risk Manag. 2005; 1(2):101-9.
Score: 0.039
-
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. Europace. 2022 07 21; 24(7):1119-1126.
Score: 0.032
-
Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019 Nov 01; 21(11):1686-1693.
Score: 0.027
-
Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol. 2019 08; 42(8):1105-1110.
Score: 0.026
-
Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019 04; 30(4):569-574.
Score: 0.026
-
Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol. 2018 12; 29(12):1697-1704.
Score: 0.025
-
To retrieve, or not to retrieve: System revisions with the Micra transcatheter pacemaker. Heart Rhythm. 2017 12; 14(12):1801-1806.
Score: 0.023
-
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 07; 38(10):730-738.
Score: 0.022
-
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017 05; 14(5):702-709.
Score: 0.022
-
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm. 2017 05; 14(5):685-691.
Score: 0.022
-
Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015 Oct 01; 36(37):2510-9.
Score: 0.020
-
The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker. Europace. 2015 May; 17(5):807-13.
Score: 0.020
-
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
Score: 0.019
-
Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial. Am Heart J. 2014 Apr; 167(4):429-36.
Score: 0.018
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
Score: 0.018
-
The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jan; 25(1):43-51.
Score: 0.018
-
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
Score: 0.017
-
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
Score: 0.016
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Score: 0.014